跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GANFORT 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GANFORT 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Approved
STANDARD
GANFORT 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Abbvie Deutschland Gmbh & Co. Kg
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 18, 2024
Approval ID
25d8203645404f45
Company
Abbvie Deutschland Gmbh & Co. Kg
Type
Standard
Approval Details
Approval Id
25d8203645404f45
Drug Cima Aemps Name
GANFORT 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS
Register Number
106340004IP1
Holder Company Name
Abbvie Deutschland Gmbh & Co. Kg
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Authorization Date
2024-07-18
Dosage Form
COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS
Dose
0,3 mg bimatoprost + 5 mg timolol
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Abbvie Deutschland Gmbh & Co. Kg
Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Company Information
Pharmaceutical Company Name
AbbVie Deutschland GmbH & Co. KG
Country Name
Germany
City Name
ludwigshafen am rhein,rheinland-pfalz,country_de
Address
Knollstr. 50
Website
http://www.abbvie.de
Active Ingredients
BIMATOPROST
0,3 mg
TIMOLOL MALEATO
6,8 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 18, 2024
Approval ID
25d8203645404f45
Type
Standard
Back to CIMA-AEMPS Approvals